High-impact publication describes a personalized genetic test that could predict prostate cancer recurrence

Date Posted: 
2014-11-14

A multinational study lead by Dr. Rob Bristow and including Dr. Colin Collins of the VPC was published in The Lancet Oncology and was written up in The Globe and Mail.

This publication describes a genetic test that could identify which men are at highest risk for recurrence of prostate cancer following localized treatment with surgery or radiation therapy and provide a quick and highly accurate tool to determine the optimal subsequent therapeutic approach.

Read the full Globe and Mail article here and the scientific publication here.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Terry Fox

Terry Fox Run - September 15, 2019

This year's Terry Fox Run takes place on Sunday September 15, in locations across Canada.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs

Employment

Work at the Vancouver Prostate Centre

Monday, September 16, 2019

Drs Cox, Gleave and Goldenberg awarded Prostate Cancer Canada and Movember 2019 Discovery Grants

Drs Cox, Gleave and Goldenberg
Thursday, September 12, 2019

Drs. Wyatt and Sorensen receive 2019 UBC Faculty of Medicine Awards for Distinguished Achievement

Drs Wyatt and Sorensen
Tuesday, September 10, 2019

Drs. Sorensen, Ester and Huntsman elected to Royal Society of Canada

Drs Sorensen, Ester, Huntsman